{"id":"https://openalex.org/W2766748815","doi":"https://doi.org/10.1016/j.jalz.2017.07.434","title":"[O4\u201303\u201305]: CONCOMITANT USE OF CHOLINESTERASE INHIBITORS OR MEMANTINE IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER's CLINICAL TRIALS","display_name":"[O4\u201303\u201305]: CONCOMITANT USE OF CHOLINESTERASE INHIBITORS OR MEMANTINE IS ASSOCIATED WITH COGNITIVE DECLINE IN ALZHEIMER's CLINICAL TRIALS","publication_year":2017,"publication_date":"2017-07-01","ids":{"openalex":"https://openalex.org/W2766748815","doi":"https://doi.org/10.1016/j.jalz.2017.07.434","mag":"2766748815"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2017.07.434","doi":"https://doi.org/10.1016/j.jalz.2017.07.434","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2017.07.434","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040122670","display_name":"Richard Kennedy","orcid":"https://orcid.org/0000-0003-4638-126X","observed_orcids":["https://orcid.org/0000-0003-4638-126X"]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]},{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Richard E. Kennedy","raw_affiliation_strings":["Keck School of Medicine of USC, Los Angeles, CA, USA","University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Keck School of Medicine of USC, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1174212"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036008316","display_name":"Gary Cutter","orcid":"https://orcid.org/0000-0002-8455-980X","observed_orcids":["https://orcid.org/0000-0002-8455-980X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary R. Cutter","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059020389","display_name":"Lon S. S. Schneider","orcid":"https://orcid.org/0000-0002-4636-6150","observed_orcids":["https://orcid.org/0000-0002-4636-6150"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lon S. Schneider","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL, USA","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5040122670"],"corresponding_institution_ids":["https://openalex.org/I1174212","https://openalex.org/I32389192"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23395419,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"7S_Part_25","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.9014000296592712,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.07419999688863754,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9419999718666077},{"id":"https://openalex.org/keywords/cholinesterase-inhibitors","display_name":"cholinesterase inhibitors","score":0.9879999756813049}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.9204705357551575},{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.8413195610046387},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.7871246337890625},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.756594717502594},{"id":"https://openalex.org/C2776332859","wikidata":"https://www.wikidata.org/wiki/Q411887","display_name":"Rivastigmine","level":5,"score":0.6635282039642334},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.5859373807907104},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5727388858795166},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.5547522306442261},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49000611901283264},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4640437960624695},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45465022325515747},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4309825599193573},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.425680547952652},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4156414866447449},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3615642189979553},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2745944857597351}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2017.07.434","doi":"https://doi.org/10.1016/j.jalz.2017.07.434","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2017.07.434","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2900332872","https://openalex.org/W2892203064","https://openalex.org/W2910436983","https://openalex.org/W2124234893","https://openalex.org/W2897220972","https://openalex.org/W1986715793","https://openalex.org/W2105599318","https://openalex.org/W2161811803","https://openalex.org/W4416778769","https://openalex.org/W2149626554"],"abstract_inverted_index":{"Clinical":[0],"trials":[1,191,204,255],"in":[2,200,231,250],"Alzheimer's":[3,28],"disease":[4],"generally":[5],"allow":[6],"subjects":[7,84,104,123,127,142,199],"to":[8,78,126,196,221],"continue":[9],"taking":[10,50,85,124,129,144,152,156,161,166,205],"concomitant":[11,97],"medications,":[12,98],"including":[13],"cholinesterase":[14],"inhibitors":[15],"(ChEIs)":[16],"and":[17,76,96,119,158,246],"memantine,":[18,153],"if":[19],"the":[20,27,94,109,137,177,188,214,222,227,232,244,251,272],"dose":[21],"is":[22,55,218],"stable.":[23],"Previous":[24],"analysis":[25],"of":[26,42,60,65,72,81,102,112,141,174,187,211,226,236,253,256],"Disease":[29],"Neuroimaging":[30],"Initiative":[31],"(ADNI)":[32],"observational":[33,197],"study":[34],"indicates":[35],"that":[36],"such":[37,51],"individuals":[38],"experience":[39,207],"greater":[40,171,209],"rate":[41,111,173,210],"decline":[43,82,113,175,212],"on":[44,93,176,213,243],"cognitive":[45],"testing":[46],"than":[47],"those":[48,165],"not":[49,56,128],"medications.":[52],"However,":[53],"it":[54],"known":[57],"whether":[58],"use":[59,235],"ChEIs/memantine":[61,125,167,206,237,266],"would":[62],"affect":[63],"results":[64],"clinical":[66,203,254],"trials.":[67],"We":[68,87,107],"used":[69],"a":[70,100,169,208],"metadatabase":[71],"18":[73],"ADCS":[74],"studies":[75,90],"ADNI":[77],"examine":[79],"rates":[80,121],"for":[83,122,260,274],"ChEIs/memantine.":[86],"included":[88],"8":[89,138,189],"with":[91,99,105,185,241],"data":[92],"ADAS-cog":[95,178,245],"total":[101],"2,290":[103],"AD.":[106,261],"estimated":[108],"annual":[110,172],"using":[114,132],"linear":[115],"mixed":[116],"effects":[117,134],"models,":[118],"compared":[120],"either":[130],"medication":[131],"random":[133],"meta-analysis.":[135],"Across":[136],"studies,":[139,198],"40.4%":[140],"were":[143,151,155,160],"ChEIs":[145],"(donepezil,":[146],"rivastigmine,":[147],"or":[148],"galantamine),":[149],"2.3%":[150],"42.4%":[154],"both,":[157],"14.8%":[159],"neither.":[162],"Meta-analysis":[163],"showed":[164],"had":[168],"significantly":[170],"(2.16":[179],"points/year,":[180],"95%":[181],"CI":[182],"[1.066,":[183],"3.262]),":[184],"3":[186],"individual":[190],"showing":[192],"significant":[193],"differences.":[194],"Similar":[195],"many":[201],"AD":[202],"ADAS-cog.":[215],"This":[216],"difference":[217],"often":[219],"comparable":[220],"hypothesized":[223],"effect":[224],"size":[225],"treatment":[228],"being":[229],"investigated":[230],"trial.":[233],"Concomitant":[234],"may":[238],"be":[239,248,268],"confounded":[240],"outcomes":[242],"should":[247],"considered":[249],"design":[252],"potential":[257,273],"therapeutic":[258],"agents":[259],"Post-hoc":[262],"analyses":[263],"stratifying":[264],"by":[265],"must":[267],"interpreted":[269],"cautiously":[270],"given":[271],"confounding.":[275]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-11-10T00:00:00"}